Stocklore

Molina Healthcare, Inc. (MOH)

Biotech & Health · US stock

What changed in recent filings

  • Institutions — 3 new · 2 added13F · as of end of 2026 Q2

What changed in recent SEC filings — factual, not a buy/sell recommendation.

Institutions holding Molina Healthcare, Inc.

How many of the institutions we track reported holding this stock, quarter by quarter.

max 6
2019 Q1 · 12019 Q2 · 22019 Q3 · 22019 Q4 · 42020 Q1 · 32020 Q2 · 32020 Q3 · 52020 Q4 · 32021 Q1 · 22021 Q2 · 42021 Q3 · 32021 Q4 · 22022 Q1 · 22022 Q2 · 12022 Q3 · 32022 Q4 · 42023 Q1 · 32023 Q2 · 32023 Q3 · 12023 Q4 · 12024 Q1 · 22024 Q2 · 22024 Q3 · 22024 Q4 · 22025 Q1 · 22025 Q2 · 42025 Q3 · 32025 Q4 · 42026 Q1 · 52026 Q2 · 6
19 Q122 Q326 Q2

2019 Q1: 1 → 2026 Q2: 6 institutions

Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.

Which institutions hold Molina Healthcare, Inc.

Institutions we track that reported holding this stock in their most recent 13F.

  • Bridgewater Associates0.01% of portfolio · since 2022 Q4
  • Tudor Investment Corp0.03% of portfolio · since 2024 Q4
  • Baupost Group2.68% of portfolio · since 2025 Q4
  • Harris Associates (Oakmark)0.29% of portfolio · held as of 2026 Q2 or earlier
  • Capital World Investors0.07% of portfolio · held as of 2026 Q2 or earlier
  • Blackstoneunder 0.01% of portfolio · held as of 2026 Q2 or earlier

Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.

Company overview

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.

What is the Biotech & Health sector?

Pharma, biotech, and medical devices. Driven by trial-result events.

Molina Healthcare, Inc. is classified under the Biotech & Health sector. See peers below.

ETFs holding Molina Healthcare, Inc.

Per SEC N-PORT · 2026-06-30 · by weight · factual

VTIVANGUARD TOTAL STOCK MARKET INDEX FUND
0.02%
ITOTiShares Core S&P Total U.S. Stock Market ETF
0.02%

MOH on Stocklore

  • Revenue by segmentsegment weights verified from SEC filings, YoY changes, growth drivers and concentration
  • Financials & earnings quality6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
  • 13F institutional holdingsholdings and weight changes of major institutions (45-day delay)
  • Sector-relative metricsValuation and growth compared with the Biotech & Health average
See full MOH analysis →

Peers · Biotech & Health

MOH FAQ

What is Molina Healthcare, Inc. (MOH)?

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.

What sector is Molina Healthcare, Inc. in?

Molina Healthcare, Inc. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.

Where can I analyze Molina Healthcare, Inc. (MOH) stock?

On Stocklore you can see MOH's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.

Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.

Not an investment adviser and not personalized investment advice; not a discretionary management service. No trade recommendations, no target prices, no execution or brokerage. We do not recommend or guarantee any purchase, sale, or returns. Investment decisions and their outcomes are your own.

Stocklore · CEO Lee Seung-jae · Business reg. no. 764-36-01607 · E-commerce permit 2026-Jeonju Wansan-0476 · Tel +82-70-7954-4939 · S120, Rm 302, 3F, 21 Jungsanjungang-ro, Wansan-gu, Jeonju, Jeonbuk, Korea